Taysha Gene Therapies
TSHA
TSHA
46 hedge funds and large institutions have $363M invested in Taysha Gene Therapies in 2020 Q3 according to their latest regulatory filings, with 46 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
46
Holders Change
+46
Holders Change %
–
% of All Funds
0.93%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
46
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$90.1M |
| 2 |
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO)
Austin,
Texas
|
+$44.8M |
| 3 |
BlackRock
New York
|
+$41.2M |
| 4 |
AG
Artal Group
Luxembourg
|
+$25.6M |
| 5 |
CC
Casdin Capital
New York
|
+$18.4M |
Top Sellers
No sellers this quarter
